Prothymosin α and cell death mode switch, a novel target for the prevention of cerebral ischemia-induced damage

Pharmacology and Therapeutics

Volumn 123, Issue 3, 2009, Pages 323-333

  Ueda, Hiroshi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

Author keywords

Apoptosis; Brain derived neurotrophic factor; Glia; Glucose transporter; Necrosis; Protein kinase C

Indexed keywords

ADENOSINE TRIPHOSPHATE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BASIC FIBROBLAST GROWTH FACTOR; BIM PROTEIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 12; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; DEOXYRIBONUCLEASE; ERYTHROPOIETIN; FAS ANTIGEN; FAS ASSOCIATED DEATH DOMAIN PROTEIN; NERVE GROWTH FACTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROCASPASE 9; PROTEIN BAD; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN BID; PROTEIN KINASE B; PROTHYMOSIN ALPHA; RECOMBINANT BRAIN DERIVED NEUROTROPHIC FACTOR; SERINE PROTEINASE OMI; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; APOPTOSIS; BRAIN ISCHEMIA; BRAIN NERVE CELL; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENCY; DRUG TARGETING; ENZYME ACTIVATION; ENZYME DEGRADATION; FIBRINOLYTIC THERAPY; HUMAN; IN VIVO STUDY; LEARNING DISORDER; LOW DRUG DOSE; MEMORY DISORDER; MOTOR DYSFUNCTION; NERVE CELL CULTURE; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA ISCHEMIA; REVIEW; STROKE; SYSTEMIC THERAPY; TRAUMATIC BRAIN INJURY;

ANIMALS; APOPTOSIS; BRAIN ISCHEMIA; CELL DEATH; DRUG DELIVERY SYSTEMS; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; ISCHEMIA; NECROSIS; NEURONS; PROTEIN PRECURSORS; RETINAL DISEASES; THYMOSIN;

EID: 67849119416     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2009.05.007     Document Type: Review

References (119)

1. A controlled trial of recombinant methionyl human BDNF in ALS: the BDNF Study Group (Phase III). Neurology 52 7 (1999) 1427-1433
2. Adachi K., Fujita Y., Morizane C., Akaike A., Ueda M., Satoh M., et al. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur J Pharmacol 350 1 (1998) 53-57
3. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 5381 (1998) 1322-1326
4. Ando A., Yonezawa K., Gout I., Nakata T., Ueda H., Hara K., et al. A complex of GRB2-dynamin binds to tyrosine-phosphorylated insulin receptor substrate-1 after insulin treatment. EMBO J 13 13 (1994) 3033-3038
5. Ashkenazi A., and Dixit V.M. Death receptors: signaling and modulation. Science 281 5381 (1998) 1305-1308
6. Ay H., Ay I., Koroshetz W.J., and Finklestein S.P. Potential usefulness of basic fibroblast growth factor as a treatment for stroke. Cerebrovasc Dis 9 3 (1999) 131-135
7. Ay I., Sugimori H., and Finklestein S.P. Intravenous basic fibroblast growth factor (bFGF) decreases DNA fragmentation and prevents downregulation of Bcl-2 expression in the ischemic brain following middle cerebral artery occlusion in rats. Brain Res Mol Brain Res 87 1 (2001) 71-80
8. Baker S.J., and Reddy E.P. Modulation of life and death by the TNF receptor superfamily. Oncogene 17 25 (1998) 3261-3270
9. Belzacq A.S., Vieira H.L., Verrier F., Vandecasteele G., Cohen I., Prevost M.C., et al. Bcl-2 and Bax modulate adenine nucleotide translocase activity. Cancer Res 63 2 (2003) 541-546
10. Bianco N.R., and Montano M.M. Regulation of prothymosin alpha by estrogen receptor alpha: molecular mechanisms and relevance in estrogen-mediated breast cell growth. Oncogene 21 34 (2002) 5233-5244
11. Bogousslavsky J., Victor S.J., Salinas E.O., Pallay A., Donnan G.A., Fieschi C., et al. Fiblast (trafermin) in acute stroke: results of the European-Australian phase II/III safety and efficacy trial. Cerebrovasc Dis 14 3-4 (2002) 239-251
12. Borsello T., Clarke P.G., Hirt L., Vercelli A., Repici M., Schorderet D.F., et al. A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat Med 9 9 (2003) 1180-1186
13. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., et al. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A 97 19 (2000) 10526-10531
14. Burkhalter J., Fiumelli H., Allaman I., Chatton J.Y., and Martin J.L. Brain-derived neurotrophic factor stimulates energy metabolism in developing cortical neurons. J Neurosci 23 23 (2003) 8212-8220
15. Chen G., and Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science 296 5573 (2002) 1634-1635
16. Chen D., and Zhou Q. Caspase cleavage of BimEL triggers a positive feedback amplification of apoptotic signaling. Proc Natl Acad Sci U S A 101 5 (2004) 1235-1240
17. Cheng Y., Deshmukh M., D'Costa A., Demaro J.A., Gidday J.M., Shah A., et al. Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 101 9 (1998) 1992-1999
18. Cheng C.M., Reinhardt R.R., Lee W.H., Joncas G., Patel S.C., and Bondy C.A. Insulin-like growth factor 1 regulates developing brain glucose metabolism. Proc Natl Acad Sci U S A 97 18 (2000) 10236-10241
19. Clinton M., Graeve L., el-Dorry H., Rodriguez-Boulan E., and Horecker B.L. Evidence for nuclear targeting of prothymosin and parathymosin synthesized in situ. Proc Natl Acad Sci U S A 88 15 (1991) 6608-6612
20. Cory S., Huang D.C., and Adams J.M. The Bcl-2 family: roles in cell survival and oncogenesis. Oncogene 22 53 (2003) 8590-8607
21. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 2 (2004) 205-219
22. Danton G.H., and Dietrich W.D. Inflammatory mechanisms after ischemia and stroke. J Neuropathol Exp Neurol 62 2 (2003) 127-136
23. Davies A.M. Intrinsic programmes of growth and survival in developing vertebrate neurons. Trends Neurosci 17 5 (1994) 195-199
24. Diaz-Horta O., Kamagate A., Herchuelz A., and Van Eylen F. Na/Ca exchanger overexpression induces endoplasmic reticulum-related apoptosis and caspase-12 activation in insulin-releasing BRIN-BD11 cells. Diabetes 51 6 (2002) 1815-1824
25. Dirnagl U., Iadecola C., and Moskowitz M.A. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 22 9 (1999) 391-397
26. Du C., Fang M., Li Y., Li L., and Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102 1 (2000) 33-42
27. Ducluzeau P.H., Fletcher L.M., Vidal H., Laville M., and Tavare J.M. Molecular mechanisms of insulin-stimulated glucose uptake in adipocytes. Diabetes Metab 28 2 (2002) 85-92
28. Edinger A.L., and Thompson C.B. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 16 6 (2004) 663-669
29. Eguchi Y., Shimizu S., and Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res 57 10 (1997) 1835-1840
30. Enari M., Sakahira H., Yokoyama H., Okawa K., Iwamatsu A., and Nagata S. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature 391 6662 (1998) 43-50
31. Evan G., and Littlewood T. A matter of life and cell death. Science 281 5381 (1998) 1317-1322
32. Ferri K.F., and Kroemer G. Organelle-specific initiation of cell death pathways. Nat Cell Biol 3 11 (2001) E255-263
33. Fujita R., and Ueda H. Protein kinase C-mediated cell death mode switch induced by high glucose. Cell Death Differ 10 12 (2003) 1336-1347
34. Fujita R., and Ueda H. Protein kinase C-mediated necrosis-apoptosis switch of cortical neurons by conditioned medium factors secreted under the serum-free stress. Cell Death Differ 10 7 (2003) 782-790
35. Fujita R., and Ueda H. Prothymosin-alpha1 prevents necrosis and apoptosis following stroke. Cell Death Differ 14 10 (2007) 1839-1842
36. Fujita R., Ueda M., Fujiwara K., and Ueda H. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Cell Death Differ 16 2 (2009) 349-358
37. Fujita R., Yoshida A., Mizuno K., and Ueda H. Cell density-dependent death mode switch of cultured cortical neurons under serum-free starvation stress. Cell Mol Neurobiol 21 4 (2001) 317-324
38. Gast K., Damaschun H., Eckert K., Schulze-Forster K., Maurer H.R., Muller-Frohne M., et al. Prothymosin alpha: a biologically active protein with random coil conformation. Biochemistry 34 40 (1995) 13211-13218
39. Gilgun-Sherki Y., Rosenbaum Z., Melamed E., and Offen D. Antioxidant therapy in acute central nervous system injury: current state. Pharmacol Rev 54 2 (2002) 271-284
40. Gladstone D.J., Black S.E., and Hakim A.M. Toward wisdom from failure: lessons from neuroprotective stroke trials and new therapeutic directions. Stroke 33 8 (2002) 2123-2136
41. Gomez-Marquez J. Function of prothymosin alpha in chromatin decondensation and expression of thymosin beta-4 linked to angiogenesis and synaptic plasticity. Ann N Y Acad Sci 1112 (2007) 201-209
42. Gozuacik D., and Kimchi A. Autophagy as a cell death and tumor suppressor mechanism. Oncogene 23 16 (2004) 2891-2906
43. Gozuacik D., and Kimchi A. Autophagy and cell death. Curr Top Dev Biol 78 (2007) 217-245
44. Green D.R., and Reed J.C. Mitochondria and apoptosis. Science 281 5381 (1998) 1309-1312
45. Hamabe W., Fukushima N., Yoshida A., and Ueda H. Serum-free induced neuronal apoptosis-like cell death is independent of caspase activity. Brain Res Mol Brain Res 78 1-2 (2000) 186-191
46. Haritos A.A., Blacher R., Stein S., Caldarella J., and Horecker B.L. Primary structure of rat thymus prothymosin alpha. Proc Natl Acad Sci U S A 82 2 (1985) 343-346
47. Heales S.J., Bolanos J.P., Stewart V.C., Brookes P.S., Land J.M., and Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1410 2 (1999) 215-228
48. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6 8 (1986) 2155-2162
49. Henderson C.E., Camu W., Mettling C., Gouin A., Poulsen K., Karihaloo M., et al. Neurotrophins promote motor neuron survival and are present in embryonic limb bud. Nature 363 6426 (1993) 266-270
50. Herrmann O., Baumann B., de Lorenzi R., Muhammad S., Zhang W., Kleesiek J., et al. IKK mediates ischemia-induced neuronal death. Nat Med 11 12 (2005) 1322-1329
51. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24 (2001) 677-736
52. Jiang X., Kim H.E., Shu H., Zhao Y., Zhang H., Kofron J., et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299 5604 (2003) 223-226
53. Kaplan D.R., and Miller F.D. Neurotrophin signal transduction in the nervous system. Curr Opin Neurobiol 10 3 (2000) 381-391
54. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26 4 (1972) 239-257
55. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat Med 3 6 (1997) 614-620
56. Kroemer G., Galluzzi L., Vandenabeele P., Abrams J., Alnemri E.S., Baehrecke E.H., et al. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16 1 (2009) 3-11
57. Lai A.Y., and Todd K.G. Microglia in cerebral ischemia: molecular actions and interactions. Can J Physiol Pharmacol 84 1 (2006) 49-59
58. Leist M., Single B., Castoldi A.F., Kuhnle S., and Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J Exp Med 185 8 (1997) 1481-1486
59. Levine B., and Yuan J. Autophagy in cell death: an innocent convict?. J Clin Invest 115 10 (2005) 2679-2688
60. Li L.Y., Luo X., and Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412 6842 (2001) 95-99
61. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 79 4 (1999) 1431-1568
62. Liu X., Kim C.N., Yang J., Jemmerson R., and Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86 1 (1996) 147-157
63. Luo X., Budihardjo I., Zou H., Slaughter C., and Wang X. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94 4 (1998) 481-490
64. Malis C.D., and Bonventre J.V. Susceptibility of mitochondrial membranes to calcium and reactive oxygen species: implications for ischemic and toxic tissue damage. Prog Clin Biol Res 282 (1988) 235-259
65. Martini P.G., Delage-Mourroux R., Kraichely D.M., and Katzenellenbogen B.S. Prothymosin alpha selectively enhances estrogen receptor transcriptional activity by interacting with a repressor of estrogen receptor activity. Mol Cell Biol 20 17 (2000) 6224-6232
66. Martinou J.C., and Green D.R. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2 1 (2001) 63-67
67. Matsunaga H., and Ueda H. Evidence for serum-deprivation-induced co-release of FGF-1 and S100A13 from astrocytes. Neurochem Int 49 3 (2006) 294-303
68. 2+ channel activity regulates the interaction between FGF-1 and S100A13 for stress-induced non-vesicular release. Cell Mol Neurobiol 26 3 (2006) 237-246
69. Mattson M.P., and Camandola S. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest 107 3 (2001) 247-254
70. Nagata S. Apoptosis by death factor. Cell 88 3 (1997) 355-365
71. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403 6765 (2000) 98-103
72. Nakajima K., and Kohsaka S. Microglia: neuroprotective and neurotrophic cells in the central nervous system. Curr Drug Targets Cardiovasc Haematol Disord 4 1 (2004) 65-84
73. Nishitoh H., Saitoh M., Mochida Y., Takeda K., Nakano H., Rothe M., et al. ASK1 is essential for JNK/SAPK activation by TRAF2. Mol Cell 2 3 (1998) 389-395
74. Nishitoh H., Matsuzawa A., Tobiume K., Saegusa K., Takeda K., Inoue K., et al. ASK1 is essential for endoplasmic reticulum stress-induced neuronal cell death triggered by expanded polyglutamine repeats. Genes Dev 16 11 (2002) 1345-1355
75. O'Connor L., Strasser A., O'Reilly L.A., Hausmann G., Adams J.M., Cory S., et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J 17 2 (1998) 384-395
76. Olson L., Nordberg A., von Holst H., Backman L., Ebendal T., Alafuzoff I., et al. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect 4 1 (1992) 79-95
77. Ono Y., Kurokawa T., Fujii T., Kawahara K., Igarashi K., Kikkawa U., et al. Two types of complementary DNAs of rat brain protein kinase C. Heterogeneity determined by alternative splicing. FEBS Lett 206 2 (1986) 347-352
78. Patapoutian A., and Reichardt L.F. Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11 3 (2001) 272-280
79. Paul R., Zhang Z.G., Eliceiri B.P., Jiang Q., Boccia A.D., Zhang R.L., et al. Src deficiency or blockade of Src activity in mice provides cerebral protection following stroke. Nat Med 7 2 (2001) 222-227
80. Pineiro A., Cordero O.J., and Nogueira M. Fifteen years of prothymosin alpha: contradictory past and new horizons. Peptides 21 9 (2000) 1433-1446
81. Pineiro A., Begona Bugia M., Pilar Arias M., Cordero O.J., and Nogueira M. Identification of receptors for prothymosin alpha on human lymphocytes. Biol Chem 382 10 (2001) 1473-1482
82. Raff M.C. Social controls on cell survival and cell death. Nature 356 6368 (1992) 397-400
83. Riccio A., Ahn S., Davenport C.M., Blendy J.A., and Ginty D.D. Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286 5448 (1999) 2358-2361
84. Rodeck U., Jost M., DuHadaway J., Kari C., Jensen P.J., Risse B., et al. Regulation of Bcl-xL expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor. Proc Natl Acad Sci U S A 94 10 (1997) 5067-5072
85. Sakahira H., Enari M., and Nagata S. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis. Nature 391 6662 (1998) 96-99
86. Salgado F.J., Pineiro A., Canda-Sanchez A., Lojo J., and Nogueira M. Prothymosin alpha-receptor associates with lipid rafts in PHA-stimulated lymphocytes. Mol Membr Biol 22 3 (2005) 163-176
87. Sasaki Y., Fukushima N., Yoshida A., and Ueda H. Low-density induced apoptosis of cortical neurons is inhibited by serum factors. Cell Mol Neurobiol 18 5 (1998) 487-496
88. Scott B.S., and Fisher K.C. Potassium concentration and number of neurons in cultures of dissociated ganglia. Exp Neurol 27 1 (1970) 16-22
89. Segade F., and Gomez-Marquez J. Prothymosin alpha. Int J Biochem Cell Biol 31 11 (1999) 1243-1248
90. Shiau A.L., Chen S.Y., Chang M.Y., Su C.H., Chung S.Y., Yo Y.T., et al. Prothymosin alpha lacking the nuclear localization signal as an effective gene therapeutic strategy in collagen-induced arthritis. J Immunol 178 7 (2007) 4688-4694
91. Shimizu S., Konishi A., Kodama T., and Tsujimoto Y. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. Proc Natl Acad Sci U S A 97 7 (2000) 3100-3105
92. Sofroniew M.V., Howe C.L., and Mobley W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24 (2001) 1217-1281
93. Sprick M.R., and Walczak H. The interplay between the Bcl-2 family and death receptor-mediated apoptosis. Biochim Biophys Acta 1644 2-3 (2004) 125-132
94. Susin S.A., Lorenzo H.K., Zamzami N., Marzo I., Snow B.E., Brothers G.M., et al. Molecular characterization of mitochondrial apoptosis-inducing factor. Nature 397 6718 (1999) 441-446
95. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., and Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell 8 3 (2001) 613-621
96. Swanson R.A., Ying W., and Kauppinen T.M. Astrocyte influences on ischemic neuronal death. Curr Mol Med 4 2 (2004) 193-205
97. Szeto H.H. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 8 3 (2006) E521-531
98. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 333 24 (1995) 1581-1587
99. Tsujimoto Y. Bcl-2 family of proteins: life-or-death switch in mitochondria. Biosci Rep 22 1 (2002) 47-58
100. Tsujimoto Y. Cell death regulation by the Bcl-2 protein family in the mitochondria. J Cell Physiol 195 2 (2003) 158-167
101. Tsukahara T., Yonekawa Y., Tanaka K., Ohara O., Wantanabe S., Kimura T., et al. The role of brain-derived neurotrophic factor in transient forebrain ischemia in the rat brain. Neurosurgery 34 2 (1994) 323-331 discussion 331
102. Turner M.R., Parton M.J., and Leigh P.N. Clinical trials in ALS: an overview. Semin Neurol 21 2 (2001) 167-175
103. Ueda H., and Fujita R. Cell death mode switch from necrosis to apoptosis in brain. Biol Pharm Bull 27 7 (2004) 950-955
104. Ueda M., Fujita R., Koji T., and Ueda H. The cognition-enhancer nefiracetam inhibits both necrosis and apoptosis in retinal ischemic models in vitro and in vivo. J Pharmacol Exp Ther 309 1 (2004) 200-207
105. Ueda H., Fujita R., Yoshida A., Matsunaga H., and Ueda M. Identification of prothymosin-alpha1, the necrosis-apoptosis switch molecule in cortical neuronal cultures. J Cell Biol 176 6 (2007) 853-862
106. Urano F., Wang X., Bertolotti A., Zhang Y., Chung P., Harding H.P., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287 5453 (2000) 664-666
107. Vande Velde C., Cizeau J., Dubik D., Alimonti J., Brown T., Israels S., et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore. Mol Cell Biol 20 15 (2000) 5454-5468
108. Walczak H., and Krammer P.H. The CD95 (APO-1/Fas) and the TRAIL (APO-2L) apoptosis systems. Exp Cell Res 256 1 (2000) 58-66
109. Watson R.T., and Pessin J.E. Intracellular organization of insulin signaling and GLUT4 translocation. Recent Prog Horm Res 56 (2001) 175-193
110. Watson R.T., and Pessin J.E. Bridging the GAP between insulin signaling and GLUT4 translocation. Trends Biochem Sci 31 4 (2006) 215-222
111. Williams L.R., Varon S., Peterson G.M., Wictorin K., Fischer W., Bjorklund A., et al. Continuous infusion of nerve growth factor prevents basal forebrain neuronal death after fimbria fornix transection. Proc Natl Acad Sci U S A 83 23 (1986) 9231-9235
112. Wu D. Neuroprotection in experimental stroke with targeted neurotrophins. NeuroRx 2 1 (2005) 120-128
113. Yabe T., Wilson D., and Schwartz J.P. NFkappaB activation is required for the neuroprotective effects of pigment epithelium-derived factor (PEDF) on cerebellar granule neurons. J Biol Chem 276 46 (2001) 43313-43319
114. Yamashita T., Sawamoto K., Suzuki S., Suzuki N., Adachi K., Kawase T., et al. Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 94 2 (2005) 459-468
115. Yoneda T., Imaizumi K., Oono K., Yui D., Gomi F., Katayama T., et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J Biol Chem 276 17 (2001) 13935-13940
116. Yoshida T., Tomioka I., Nagahara T., Holyst T., Sawada M., Hayes P., et al. Bax-inhibiting peptide derived from mouse and rat Ku70. Biochem Biophys Res Commun 321 4 (2004) 961-966
117. Zamzami N., and Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol 2 1 (2001) 67-71
118. Zha J., Harada H., Yang E., Jockel J., and Korsmeyer S.J. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 87 4 (1996) 619-628
119. Zong W.X., and Thompson C.B. Necrotic death as a cell fate. Genes Dev 20 1 (2006) 1-15